Medolone

Aciclovir, the active ingredient in Medolone, is an antiviral presented as an intravenous solution for intravenous use. It treats herpes simplex virus infections, varicella‑zoster virus infections, and herpes encephalitis in patients requiring systemic therapy.

GNH USA supplies Medolone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medolone (aciclovir) is employed to manage viral infections that involve DNA replication of herpes viruses.

Herpes simplex virus infections: reduces viral replication and accelerates lesion healing. Varicella‑zoster virus infections: limits viral spread and alleviates acute dermatologic manifestations. Herpes encephalitis: suppresses viral activity in the central nervous system, improving clinical outcomes.

Common Side Effects: - Infusion site pain or phlebitis. - Headache. - Nausea or vomiting. - Fever and chills. - Rash or mild pruritus. - Elevated liver enzymes.

Serious or Rare Side Effects: - Nephrotoxicity, especially with rapid infusion. - Thrombocytopenia or leukopenia. - Seizures or neurotoxicity. - Severe hypersensitivity reactions, including anaphylaxis. - Hemolytic anemia. - Hepatic failure or severe liver injury.

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor for adverse events.

Renal function: assess baseline renal function and adjust dosing as needed. Hydration: ensure adequate hydration prior to infusion to reduce nephrotoxicity risk. Concomitant nephrotoxic drugs: avoid or monitor closely when used together. Pregnancy: prescribe only if potential benefits outweigh potential risks. Allergy: discontinue immediately if a severe hypersensitivity reaction occurs. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Aciclovir may interact with several medicines; careful assessment is required.

Major Interactions (Avoid): - Probenecid: reduces renal clearance, increasing aciclovir plasma levels. - Cimetidine: may elevate serum concentrations of aciclovir. - Nephrotoxic agents (e.g., aminoglycosides): increase risk of renal toxicity. - High‑osmolarity IV fluids: may exacerbate infusion‑related reactions.

Moderate Interactions (Monitor Closely): - Nonsteroidal anti‑inflammatory drugs: can affect renal function. - Diuretics: monitor electrolytes and renal parameters. - Other antivirals (e.g., valacyclovir): additive toxicity potential.